Enhanced oncolytic potency of replicative adenovirus expressing p53.
Nemunaitis
John
J
US Oncology, Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA. john.nemunaitis@usoncology.com
Cunningham
Casey
C
Senzer
Neil
N
D000256:Adenoviridae / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D000818:Animals; D017209:Apoptosis; D002986:Clinical Trials as Topic; D015870:Gene Expression; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D009369:Neoplasms / Q000473:pathology / Q000628:therapy*; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis* / Q000235:genetics; D014779:Virus Replication
D016159:Tumor Suppressor Protein p53